Aldoxorubicin, an antineoplastic agents, is an albumin-binding prodrug of doxorubicin.
Aldoxorubicin, an antineoplastic agents, is an albumin-binding prodrug of doxorubicin.
Investigated for use/treatment in solid tumors.
No associated conditions information available.
Stay informed with timely notifications on clinical trials and research advancements.